rs121913407, CTNNB1

N. diseases: 10
Source: CURATED ×
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Liver carcinoma
CUI: C2239176
Disease: Liver carcinoma
203 0.763 0.240 3 41224645 missense variant T/C;G snv 0.810 1.000 1 2015 2016
melanoma
CUI: C0025202
Disease: melanoma
212 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 7 1997 2004
Adenocarcinoma of lung (disorder)
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
404 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Adenocarcinoma of prostate
CUI: C0007112
Disease: Adenocarcinoma of prostate
96 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Adrenocortical carcinoma
CUI: C0206686
Disease: Adrenocortical carcinoma
34 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Brain Neoplasms
CUI: C0006118
Disease: Brain Neoplasms
122 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2014 2014
Colorectal Neoplasms
CUI: C0009404
Disease: Colorectal Neoplasms
586 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Cutaneous Melanoma
CUI: C0151779
Disease: Cutaneous Melanoma
195 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Malignant Uterine Corpus Neoplasm
CUI: C0153574
Disease: Malignant Uterine Corpus Neoplasm
152 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016
Transitional cell carcinoma of bladder
141 0.763 0.240 3 41224645 missense variant T/C;G snv 0.700 1.000 1 2016 2016